COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...


Boragen was formed to develop synthetic fungicides based on a group of boron-containing compounds. In 2022, the company split into three separate companies, 5Metis, Borah and Reactive Biosciences.
Boragen
Research Triangle Park, NC